Biogen backs away from AGTC after gene therapy failure

Biogen backs away from AGTC after gene therapy failure

Submitted by admin on December 13, 2018 - 9:10pm
Source: 
BioPharma Dive
News Tags: 
gene therapy
Biogen
Applied Genetic Technologies
Headline: 
Biogen backs away from AGTC after gene therapy failure
snippet: 

Gene therapy developer AGTC lost nearly half its market cap Thursday morning after Biogen exited a collaboration agreement on the heels of a big clinical failure.

Do Not Allow Advertisers to Use My Personal information